Available Technologies for Licensing
Office of Technology Development
The Immune Disease Institute
Simmons College
2 Avenue Louis Pasteur
Boston, MA 02115
Ryan Dietz
Director, Office of Technology Development
Phone: 617.919.3048
Below is a partial list of areas in which the IDI has established patent positions. Contact (JavaScript must be enabled to view this email address) for more information.
-
Fully Human Anti-LFA-1 Antibody Treating Inflammation and Autoimmune Disease
ID #: 00-004 and 06-004Inventor(s): Timothy Springer, Ph.D., et al. -
Monocyte Locomotion Inhibitory Factor (MLIF) - Peptide for anti-inflammation and Scarring
ID #: 98-002Inventor(s): Roberto R. Kretschmer, M.D. -
CORVUS - Blood-Brain Barrier and Neuronal Cell Drug Delivery Method and Reagents
ID #: IDI 06-001Inventor(s): Manjunath Narasimhaswamy, M.D. -
High Affinity I-Domain as Anti-Inflammatory or Immunosuppressant
ID #: IDI 05-004Inventor(s): Timothy A. Springer, Ph.D. & Moonsoo Jin, Ph.D. -
Cell-Type Specific Systemic Delivery of siRNA
ID #: IDI 04-002Inventor(s): Judy Lieberman, M.D., Ph.D. & Erwei Song, Ph.D. -
Treatment and Prevention of Inflammatory Bowel Disease
ID #: IDI 03-008Inventor(s): Manjunath Narasimhaswamy, M.D. & Amale Laouar, Ph.D. -
Isolation and Enrichment of Dendritic Cells Useful for Vaccines
ID #: IDI 96-001Inventor(s): Keith D. Crawford, M.D., Ph.D. & Chester A. Alper, M.D. -
Topical Anti-Microbial Agents for the Prevention of STDs
ID #: IDI 02-001Inventor(s): Judy Lieberman, M.D., Ph.D. -
Monocyte/Neutrophil Elastase Inhibitor
ID #: IDI 89-001Inventor(s): Eileen Remold-O’Donnell, Ph.D. -
Selective Inhibition of Calcineurin-NFAT Signaling
ID #: IDI 98-001Inventor(s): Patrick G. Hogan, Ph.D. -
Methods for Treating Hemostatic Disorders by Modulating P-Selectin Activity (Anti-Thrombotic)
ID #: IDI 00-009Inventor(s): Denisa Wagner, Ph.D., et al -
Methods for Diagnosing Thrombotic Disorders
ID #: IDI 00-009Inventor(s): Denisa Wagner, Ph.D., et al.
